| Current Price | $50.03 | Mkt Cap | $71.9B |
|---|---|---|---|
| Open | $49.80 | P/E Ratio | 94.27 |
| Prev. Close | $50.03 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $49.69 - $50.21 | Volume | 11,585,749 |
| 52-Wk Range | $34.98 - $50.21 | Avg. Daily Vol. | 7,866,374 |
The Company develops, manufactures & markets medical devices that are used in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology & neuromodulation.
| Current Price | $50.03 | Mkt Cap | $71.9B |
|---|---|---|---|
| Open | $49.80 | P/E Ratio | 94.27 |
| Prev. Close | $50.03 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $49.69 - $50.21 | Volume | 11,585,749 |
| 52-Wk Range | $34.98 - $50.21 | Avg. Daily Vol. | 7,866,374 |
The best Bull and Bear pitches based on recency and number of recommendations.
They are generating lots of cash and rapidly paying down debt. Insider selling last fall was induced by the financial crisis and does not reflect a lack of faith in the business. Gross margin of 70%. They will likely benefit from universal health… More
Another major blunder from a company that knows all to well the consequences of such a major mistake. Please take my advice when I tell you this ship is sinking fast.
Read the most recent pitches from players about BSX.
Recs
TMFAdriaCimino
(< 20)
Submitted: 2/20/2020 3:59:14 AM :
Start Price:
$42.31
NYSE:BSX Score:
-2.74
Boston Scientific's many devices as well as a new duodenoscope, used in ERCP procedures will drive revenue. The duodenscope is significant because it is the first FDA-cleared single use one.
Recs
plowboy
(< 20)
Submitted: 2/1/2014 1:58:59 PM :
Start Price:
$13.55
NYSE:BSX Score:
+139.45
turnaround
Recs
simonwmich
(< 20)
Submitted: 1/18/2014 5:36:14 PM :
Start Price:
$13.82
NYSE:BSX Score:
+140.63
Stock has almost tripled over the past year and game changing technologies forthcoming with 1H14 expected launch of Watchman A Fib device. Company could also benefit the most from MDT Simplicity renal denervation failure.
Find the members with the highest scoring picks in BSX.
Boum (< 20) Score: +700.90
The Score Leader is the player with the highest score across all their picks in BSX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Boum | < 20 | 7/26/2012 |
|
5Y | $4.99 | +901.80% | +200.91% | +700.90 | 0 Comment | |
| akim088 | < 20 | 7/27/2012 |
|
1Y | $5.02 | +895.82% | +198.31% | +697.50 | 1 Comment | |
| morten1952 | 98.24 | 10/25/2012 |
|
5Y | $5.15 | +870.68% | +187.54% | +683.14 | 0 Comment | |
| eljuden21 | 84.99 | 7/30/2012 |
|
1Y | $5.18 | +865.06% | +194.80% | +670.26 | 0 Comment | |
| TessaFaye | 64.40 | 1/4/2012 |
|
5Y | $5.32 | +839.66% | +221.04% | +618.62 | 0 Comment | |
|
adamotocross48 | 76.11 |
|
|
3Y | $5.32 | +839.66% | +226.82% | +612.84 | 0 Comment |
| lusito1779 | < 20 | 1/13/2012 |
|
5Y | $5.45 | +817.25% | +218.11% | +599.14 | 0 Comment | |
| ttodisco | < 20 | 6/27/2012 |
|
1Y | $5.55 | +800.72% | +208.38% | +592.34 | 1 Comment | |
| StudlyDoRight | 64.92 | 9/2/2010 |
|
5Y | $5.18 | +865.06% | +275.40% | +589.66 | 0 Comment | |
| BooBearsDad | < 20 | 10/26/2011 |
|
3M | $5.44 | +819.78% | +231.92% | +587.86 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
